Vanguard Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86.7M Sell
3,131,602
-227,499
-7% -$6.29M ﹤0.01% 1888
2025
Q1
$74.6M Buy
3,359,101
+151,604
+5% +$3.37M ﹤0.01% 1923
2024
Q4
$63.4M Sell
3,207,497
-90,759
-3% -$1.8M ﹤0.01% 2064
2024
Q3
$82.4M Buy
+3,298,256
New +$82.4M ﹤0.01% 1964
2024
Q2
Sell
-2,981,894
Closed -$58.8M 4425
2024
Q1
$58.8M Buy
2,981,894
+16,595
+0.6% +$327K ﹤0.01% 2089
2023
Q4
$52M Buy
2,965,299
+6,342
+0.2% +$111K ﹤0.01% 2176
2023
Q3
$51.4M Sell
2,958,957
-128,255
-4% -$2.23M ﹤0.01% 2126
2023
Q2
$43.5M Sell
3,087,212
-173,411
-5% -$2.44M ﹤0.01% 2246
2023
Q1
$35.1M Buy
3,260,623
+33,732
+1% +$363K ﹤0.01% 2342
2022
Q4
$48.3M Buy
3,226,891
+147,699
+5% +$2.21M ﹤0.01% 2203
2022
Q3
$39.5M Buy
3,079,192
+151,211
+5% +$1.94M ﹤0.01% 2295
2022
Q2
$28.4M Sell
2,927,981
-78,669
-3% -$762K ﹤0.01% 2470
2022
Q1
$29.9M Buy
3,006,650
+115,942
+4% +$1.15M ﹤0.01% 2566
2021
Q4
$34M Buy
2,890,708
+228,082
+9% +$2.68M ﹤0.01% 2559
2021
Q3
$30.3M Sell
2,662,626
-1,697
-0.1% -$19.3K ﹤0.01% 2638
2021
Q2
$37.1M Sell
2,664,323
-138,724
-5% -$1.93M ﹤0.01% 2525
2021
Q1
$51.9M Buy
2,803,047
+266,626
+11% +$4.94M ﹤0.01% 2294
2020
Q4
$44.8M Buy
2,536,421
+164,137
+7% +$2.9M ﹤0.01% 2260
2020
Q3
$36.3M Buy
2,372,284
+657,342
+38% +$10.1M ﹤0.01% 2171
2020
Q2
$43.7M Buy
1,714,942
+514,431
+43% +$13.1M ﹤0.01% 2069
2020
Q1
$18.6M Sell
1,200,511
-942
-0.1% -$14.6K ﹤0.01% 2327
2019
Q4
$13.3M Buy
1,201,453
+34,942
+3% +$386K ﹤0.01% 2722
2019
Q3
$9.93M Sell
1,166,511
-76,851
-6% -$654K ﹤0.01% 2819
2019
Q2
$16.8M Sell
1,243,362
-2,862
-0.2% -$38.8K ﹤0.01% 2599
2019
Q1
$22.5M Buy
1,246,224
+337,951
+37% +$6.1M ﹤0.01% 2450
2018
Q4
$25.5M Buy
908,273
+352,282
+63% +$9.9M ﹤0.01% 2336
2018
Q3
$14.2M Buy
555,991
+405,991
+271% +$10.4M ﹤0.01% 2750
2018
Q2
$2.6M Buy
+150,000
New +$2.6M ﹤0.01% 3418